Oral Answers to Questions

Douglas Carswell Excerpts

Thursday 26th January 2017 Commons Chamber

[Mr Davis]

The Prime Minister has made it plain that she has already tried to get agreement among all the member states. Most of them agree, but one or two of them do not, and we have to keep pressing, as we will, to resolve this as quickly as possible. I hope that EU nationals who are currently here will take heart from what we are saying. Our intention is to give them the guarantees that will also apply to British citizens abroad.

[Mr Douglas Carswell (Clacton) (UKIP)]

12. If he will discuss with Cabinet colleagues the future of the provisions of the EU clinical trials directives after the UK leaves the EU.

[The Secretary of State for Exiting the European Union (Mr David Davis)]

The Prime Minister’s speech set out the negotiating priority to ensure that the UK is one of the best places in the world for science and innovation. As part of the negotiations, the Government will discuss with EU member states how best to continue co-operation in the field of clinical trials. In respect of the hon. Gentleman’s question, the UK successfully applied sustained pressure to reform the current directive in the best interests of patients and business. We will follow the EU rules until the point of exit, and those new rules will come into effect shortly. The great repeal Bill will convert EU law as it applies, including EU regulations, into domestic law on exit. If needs be, we can reform the regulations after that.

[Mr Carswell]

Given the harmful effect of EU directives on clinical trials and science in the UK, when the time comes to write our own rules will the Secretary of State undertake to listen to some of the clinical practitioners and scientists, not just the big corporate vested interests whose business model depends on having an army of lobbyists in Brussels?